GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $870,000 | +9.2% | 19,987 | +9.3% | 0.06% | +22.0% |
| Q1 2022 | $797,000 | +0.6% | 18,294 | +1.9% | 0.05% | +4.2% |
| Q4 2021 | $792,000 | +28.8% | 17,955 | +11.6% | 0.05% | +14.3% |
| Q3 2021 | $615,000 | +12.4% | 16,088 | +17.0% | 0.04% | +16.7% |
| Q2 2021 | $547,000 | +13.3% | 13,748 | +1.7% | 0.04% | +2.9% |
| Q1 2021 | $483,000 | -14.7% | 13,523 | -12.0% | 0.04% | -18.6% |
| Q4 2020 | $566,000 | -11.8% | 15,367 | -9.9% | 0.04% | -21.8% |
| Q3 2020 | $642,000 | -22.3% | 17,050 | -15.8% | 0.06% | -28.6% |
| Q2 2020 | $826,000 | +54.4% | 20,255 | +43.2% | 0.08% | +18.5% |
| Q1 2020 | $535,000 | -42.5% | 14,142 | -27.6% | 0.06% | -32.3% |
| Q4 2019 | $930,000 | +27.4% | 19,538 | +14.3% | 0.10% | +9.1% |
| Q3 2019 | $730,000 | +29.7% | 17,101 | +21.5% | 0.09% | +27.5% |
| Q2 2019 | $563,000 | -8.8% | 14,080 | -4.6% | 0.07% | -12.7% |
| Q1 2019 | $617,000 | +16.4% | 14,760 | +6.5% | 0.08% | -7.1% |
| Q4 2018 | $530,000 | -21.2% | 13,862 | -17.3% | 0.08% | -6.6% |
| Q3 2018 | $673,000 | +25.6% | 16,765 | +26.0% | 0.09% | 0.0% |
| Q2 2018 | $536,000 | +49.7% | 13,303 | +45.2% | 0.09% | +37.9% |
| Q1 2018 | $358,000 | -25.3% | 9,161 | -22.8% | 0.07% | -59.5% |
| Q4 2015 | $479,000 | +10.1% | 11,866 | +4.9% | 0.16% | -10.4% |
| Q3 2015 | $435,000 | -12.5% | 11,308 | -4.8% | 0.18% | -4.2% |
| Q2 2015 | $497,000 | 0.0% | 11,879 | +10.3% | 0.19% | -10.0% |
| Q1 2015 | $497,000 | +3.1% | 10,773 | +1.2% | 0.21% | -0.9% |
| Q4 2014 | $482,000 | -4.7% | 10,640 | -3.4% | 0.21% | -26.3% |
| Q3 2014 | $506,000 | -17.3% | 11,017 | -3.7% | 0.29% | -4.0% |
| Q2 2014 | $612,000 | -0.6% | 11,437 | -0.8% | 0.30% | -10.9% |
| Q1 2014 | $616,000 | +1.1% | 11,525 | +1.1% | 0.34% | -3.4% |
| Q4 2013 | $609,000 | +9.7% | 11,398 | +3.0% | 0.35% | -11.8% |
| Q3 2013 | $555,000 | +4.7% | 11,062 | +4.4% | 0.40% | -8.5% |
| Q2 2013 | $530,000 | – | 10,598 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |